MedWatch

Danish biotech company in protein deal with US company

ExpreS2ion Biotechnologies has made a partnership deal with an American company that could result in millions for the Danish company. The long-term goal is milestone payments and royalties.

Foto: Colourbox

The Danish biotech company ExpreS2ion Biotechnologies, a two-year-old spin-off from Affitech, has recently made a partnership deal with a US pharmaceutical company.

“We have signed a collaboration deal with a major US pharmaceutical company. The deal has the potential to bring us millions. Unfortunately we cannot disclose the name of the company or any other details, as it is confidential,” says CEO Charlotte Dyring.

Allerede abonnent? Log ind.

Læs hele artiklen

Få adgang i 14 dage for 0 kr.
Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Relaterede

Seneste nyt

MedWatch job

Se flere jobs

Se flere jobs

Watch job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier